• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性地中海热中循环内皮生物标志物的评估。

Evaluation of circulating endothelial biomarkers in familial Mediterranean fever.

机构信息

Department of Internal Medicine, Bozyaka Training and Research Hospital, Izmir, Turkey.

出版信息

Rheumatol Int. 2013 Aug;33(8):1967-72. doi: 10.1007/s00296-013-2681-8. Epub 2013 Jan 29.

DOI:10.1007/s00296-013-2681-8
PMID:23358733
Abstract

The aim of this was to evaluate some of the vascular biomarkers and cytokines related with atherosclerosis in regularly treated and attack-free familial Mediterranean fever (FMF) patients. Forty (21 males [M] and 19 females [F], 31 [15-58] years) FMF patients and eighteen healthy controls (11 M and 7 F, 35.5 [19-46] years) with no known cardiovascular (CV) risk factors were included. All patients were receiving regular colchicine treatment, and examinations were performed during attack-free periods. Serum samples were used for the determination of high-sensitive C-reactive protein (hs-CRP), tissue factor (TF), tissue plasminogen activator (t-PA), osteoprotegerin (OPG), interleukin-6 (IL-6), IL-17, and IL-23. Plasma samples were used for the determination of asymmetric dimethylarginine (ADMA) and thrombomodulin (TM). Age, sex distribution, waist circumference, body mass index, smoking status, and serum lipids were similar between the patients and controls (P > 0.05). The concentrations of (hs-CRP) and IL-17 were significantly higher in FMF patients compared with controls (P < 0.05). On the other hand, IL-6 and IL-23 levels were not different between the groups (P > 0.05). ADMA, OPG, and TM concentrations were significantly lower in the patients' group compared to those of controls (P < 0.05). However, vWF, TF, and t-PA levels were similar between the groups (P > 0.05). FMF patients receiving regular colchicine therapy during inactive disease state had significantly lower levels of vascular injury parameters.

摘要

本研究旨在评估一些与动脉粥样硬化相关的血管生物标志物和细胞因子在常规治疗且无发作的家族性地中海热(FMF)患者中的变化。共纳入 40 例(21 名男性[M]和 19 名女性[F],年龄 31[15-58]岁)FMF 患者和 18 名健康对照者(11 名男性和 7 名女性,年龄 35.5[19-46]岁),这些对照者均无已知的心血管(CV)危险因素。所有患者均接受常规秋水仙碱治疗,且检查均在无发作期间进行。采集血清样本用于测定高敏 C 反应蛋白(hs-CRP)、组织因子(TF)、组织型纤溶酶原激活物(t-PA)、护骨素(OPG)、白细胞介素-6(IL-6)、白细胞介素-17(IL-17)和白细胞介素-23(IL-23)。采集血浆样本用于测定不对称二甲基精氨酸(ADMA)和血栓调节蛋白(TM)。患者与对照组间年龄、性别分布、腰围、体重指数、吸烟状态和血清脂质水平均相似(P>0.05)。与对照组相比,FMF 患者的 hs-CRP 和 IL-17 浓度明显更高(P<0.05)。另一方面,两组间 IL-6 和 IL-23 水平无差异(P>0.05)。与对照组相比,患者组的 ADMA、OPG 和 TM 浓度明显更低(P<0.05)。然而,两组间 vWF、TF 和 t-PA 水平相似(P>0.05)。在无疾病活动期接受常规秋水仙碱治疗的 FMF 患者的血管损伤参数水平显著降低。

相似文献

1
Evaluation of circulating endothelial biomarkers in familial Mediterranean fever.家族性地中海热中循环内皮生物标志物的评估。
Rheumatol Int. 2013 Aug;33(8):1967-72. doi: 10.1007/s00296-013-2681-8. Epub 2013 Jan 29.
2
Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF?家族性地中海热(FMF)青年男性中不对称二甲基精氨酸水平升高:这是FMF中炎症与内皮功能障碍相互作用的早期证据吗?
J Rheumatol. 2008 Oct;35(10):2024-9. Epub 2008 Sep 1.
3
The effect of regular colchicine treatment on biomarkers related with vascular injury in newly diagnosed patients with familial Mediterranean fever.常规秋水仙碱治疗对新诊断的家族性地中海热患者血管损伤相关生物标志物的影响。
Inflammation. 2012 Jun;35(3):1191-7. doi: 10.1007/s10753-012-9428-7.
4
Increased serum osteoprotegerin levels associated with decreased bone mineral density in familial Mediterranean fever.家族性地中海热中血清骨保护素水平升高与骨密度降低相关。
Tohoku J Exp Med. 2009 Apr;217(4):321-7. doi: 10.1620/tjem.217.321.
5
Plasma levels of soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) in familial Mediterranean fever.家族性地中海热中可溶性血管内皮生长因子受体-1(sVEGFR-1)的血浆水平
Joint Bone Spine. 2007 Jan;74(1):52-5. doi: 10.1016/j.jbspin.2006.02.003. Epub 2006 Apr 17.
6
Down-regulation of adiponectin in patients with familial Mediterranean fever during attack-free period.家族性地中海热患者无发作期脂联素水平下调。
Rheumatol Int. 2012 Sep;32(9):2819-22. doi: 10.1007/s00296-011-2094-5. Epub 2011 Aug 30.
7
Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever.秋水仙碱对家族性地中海热中炎性细胞因子和选择素的影响。
Clin Exp Rheumatol. 1998 Nov-Dec;16(6):721-4.
8
Evaluation of endothelial dysfunction in patients with familial Mediterranean fever: the relationship between the levels of asymmetric dimethylarginine and endocan with carotid intima-media thickness and endothelium-dependent vasodilation.家族性地中海热患者内皮功能障碍的评估:不对称二甲基精氨酸和内脂素水平与颈动脉内膜中层厚度和内皮依赖性血管舒张的关系。
Clin Rheumatol. 2017 Sep;36(9):2071-2077. doi: 10.1007/s10067-016-3532-2. Epub 2017 Jan 10.
9
S1000A12, Chitotriosidase, and Resolvin D1 as Potential Biomarkers of Familial Mediterranean Fever.S1000A12、壳三糖苷酶和R-脂氧素D1作为家族性地中海热的潜在生物标志物
J Korean Med Sci. 2015 Sep;30(9):1241-5. doi: 10.3346/jkms.2015.30.9.1241. Epub 2015 Aug 13.
10
Cytokine profile of Armenian patients with Familial Mediterranean fever.患有家族性地中海热的亚美尼亚患者的细胞因子谱
Clin Biochem. 2008 Jul;41(10-11):920-2. doi: 10.1016/j.clinbiochem.2008.03.017. Epub 2008 Apr 11.

引用本文的文献

1
Non-Anticoagulation Strategies Aimed at Primary Stroke Prevention in Nascent Atrial Fibrillation.针对初发心房颤动进行一级卒中预防的非抗凝策略。
Biomedicines. 2025 Mar 7;13(3):660. doi: 10.3390/biomedicines13030660.
2
Serum endocan, asymmetric dimethylarginine and lipid profile in children with familial Mediterranean fever.家族性地中海热患儿的血清内脂素、不对称二甲基精氨酸和血脂谱
Pediatr Res. 2024 Feb 23. doi: 10.1038/s41390-024-03093-8.
3
Endovascular Interventional Procedure is a Significant Risk Factor of Postsurgical Gout: A Retrospective Cohort Study.

本文引用的文献

1
The effect of regular colchicine treatment on biomarkers related with vascular injury in newly diagnosed patients with familial Mediterranean fever.常规秋水仙碱治疗对新诊断的家族性地中海热患者血管损伤相关生物标志物的影响。
Inflammation. 2012 Jun;35(3):1191-7. doi: 10.1007/s10753-012-9428-7.
2
Endothelium--role in regulation of coagulation and inflammation.内皮细胞——在凝血和炎症调节中的作用。
Semin Immunopathol. 2012 Jan;34(1):93-106. doi: 10.1007/s00281-011-0285-5. Epub 2011 Aug 4.
3
The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases.
血管内介入手术是术后痛风的一个重要危险因素:一项回顾性队列研究。
Rheumatol Ther. 2024 Feb;11(1):51-60. doi: 10.1007/s40744-023-00617-2. Epub 2023 Nov 6.
4
Colchicine in Athero-Thrombosis: Molecular Mechanisms and Clinical Evidence.秋水仙碱在动脉粥样血栓形成中的作用:分子机制和临床证据。
Int J Mol Sci. 2023 Jan 27;24(3):2483. doi: 10.3390/ijms24032483.
5
Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review.秋水仙碱在心血管医学中的治疗潜力:药理学评价。
Acta Pharmacol Sin. 2022 Sep;43(9):2173-2190. doi: 10.1038/s41401-021-00835-w. Epub 2022 Jan 19.
6
Association Between Familial Mediterranean Fever and Cachexia in Females.女性家族性地中海热与恶病质之间的关联
Arch Rheumatol. 2020 Feb 7;35(4):477-485. doi: 10.46497/ArchRheumatol.2020.7632. eCollection 2020 Dec.
7
Familial Mediterranean fever and atherosclerosis in childhood and adolescence.家族性地中海热与儿童和青少年时期的动脉粥样硬化。
Rheumatol Int. 2020 Jan;40(1):1-8. doi: 10.1007/s00296-019-04457-8. Epub 2019 Nov 8.
8
Meta-Analysis of Asymmetric Dimethylarginine Concentrations in Rheumatic Diseases.风湿性疾病中不对称二甲基精氨酸浓度的荟萃分析。
Sci Rep. 2019 Apr 1;9(1):5426. doi: 10.1038/s41598-019-41994-5.
9
Canakinumab: can it untie the Gordian knot of cardiovascular disease in patients with familial Mediterranean fever?卡那单抗:它能否解开家族性地中海热患者心血管疾病的死结?
Arch Med Sci Atheroscler Dis. 2018 Jun 29;3:e96-e98. doi: 10.5114/amsad.2018.76866. eCollection 2018.
10
Cardiovascular disease in patients with autoinflammatory syndromes.自身炎症性疾病患者的心血管疾病。
Rheumatol Int. 2018 Jan;38(1):37-50. doi: 10.1007/s00296-017-3854-7. Epub 2017 Nov 1.
白细胞介素-17 细胞因子家族:宿主防御和炎症性疾病中的关键分子。
Immunology. 2011 Sep;134(1):8-16. doi: 10.1111/j.1365-2567.2011.03465.x. Epub 2011 Jul 4.
4
Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment.自身免疫性风湿病血管功能的比较评估:预防和治疗的考虑。
Autoimmun Rev. 2011 May;10(7):416-25. doi: 10.1016/j.autrev.2011.01.004. Epub 2011 Jan 31.
5
IL-23: a promising therapeutic target for systemic lupus erythematosus.白细胞介素 23:系统性红斑狼疮的有前途的治疗靶点。
Arch Med Res. 2010 Apr;41(3):221-5. doi: 10.1016/j.arcmed.2010.02.011.
6
Emerging role of IL-17 in atherosclerosis.IL-17 在动脉粥样硬化中的新兴作用。
J Innate Immun. 2010;2(4):325-33. doi: 10.1159/000314626. Epub 2010 May 7.
7
Familial mediterranean Fever as an emerging clinical model of atherogenesis associated with low-grade inflammation.家族性地中海热作为一种与低度炎症相关的动脉粥样硬化发生的新兴临床模型。
Open Cardiovasc Med J. 2010 Feb 23;4:51-6. doi: 10.2174/1874192401004020051.
8
The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases.风湿性疾病加速动脉粥样硬化比较研究的原理。
Curr Vasc Pharmacol. 2010 Jul;8(4):437-49. doi: 10.2174/157016110791330852.
9
Increased levels of asymmetric dimethylarginine (ADMA) in patients with ankylosing spondylitis.强直性脊柱炎患者不对称二甲基精氨酸(ADMA)水平升高。
Intern Med. 2009;48(16):1363-8. doi: 10.2169/internalmedicine.48.2193. Epub 2009 Aug 17.
10
The many faces of tissue factor.组织因子的多面性
J Thromb Haemost. 2009 Jul;7 Suppl 1(Suppl 1):136-9. doi: 10.1111/j.1538-7836.2009.03368.x.